Oncogenically active MYD88 mutations in human lymphoma
Vu N. Ngo(National Cancer Institute), Ryan M. Young(National Cancer Institute), Roland Schmitz(National Cancer Institute), Sameer Jhavar(Center for Cancer Research), Wenming Xiao(Center for Information Technology), Kian‐Huat Lim(Center for Cancer Research), Holger Kohlhammer(Center for Cancer Research), Weihong Xu(Center for Cancer Research), Yandan Yang(National Cancer Institute), Hong Zhao(National Cancer Institute), Arthur L. Shaffer(National Cancer Institute), Paul B. Romesser(National Cancer Institute), George W. Wright(National Cancer Institute), John Powell(National Institutes of Health), Andreas Rosenwald(University of Würzburg), Hans Konrad Müller‐Hermelink(University of Würzburg), German Ott(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Randy D. Gascoyne(BC Cancer Agency), Joseph M. Connors(BC Cancer Agency), Lisa M. Rimsza(University of Arizona), Elı́as Campo(Universitat de Barcelona), Elaine S. Jaffe(National Cancer Institute), Jan Delabie(Oslo University Hospital), Erlend B. Smeland(University of Oslo), Richard I. Fisher(SWOG Cancer Research Network), Rita M. Braziel(Oregon Health & Science University), Raymond R. Tubbs(SWOG Cancer Research Network), James R. Cook(SWOG Cancer Research Network), D D Weisenburger(University of Nebraska Medical Center), Wing C. Chan(University of Nebraska Medical Center), Louis M. Staudt(National Cancer Institute)
Cited by 1,503Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis